Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit?

Critical Care

Volumn 14, Issue 1, 2010, Pages

  George, Philip ^a   Morris, Andrew M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; IMIPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; DECISION SUPPORT SYSTEM; DRUG COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HOSPITALIZATION COST; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; PRIORITY JOURNAL; REVIEW; SEPSIS; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; CLINICAL PRACTICE; INFECTION CONTROL; MASS COMMUNICATION; MULTIDRUG RESISTANCE; ORGANIZATION AND MANAGEMENT; PROGRAM DEVELOPMENT;

ANTI-BACTERIAL AGENTS; DIFFUSION OF INNOVATION; DRUG RESISTANCE, MULTIPLE; INFECTION CONTROL; INTENSIVE CARE UNITS; PHYSICIAN'S PRACTICE PATTERNS; PROGRAM DEVELOPMENT;

EID: 77956640252     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8219     Document Type: Review

References (49)

1. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM, . Infectious Diseases Society of America; Society for Healthcare Epidemiology of America Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-177. 10.1086/510393, 17173212, Infectious Diseases Society of America; Society for Healthcare Epidemiology of America.
2. Gerding DN. The search for good antimicrobial stewardship. Jt Comm J Qual Improv 2001, 27:403-404.
3. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: A statement by the Infectious Diseases Society of America. J Infect Dis 1988, 157:869-876.
4. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001, 33:757-762. 10.1086/322627, 11512079.
5. Marra AR, Edmond MB, Wenzel RP, Bearman GM. Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: Epidemiology, clinical course and outcome. BMC Infect Dis 2007, 7:42. 1888698, 17517130, 10.1186/1471-2334-7-42.
6. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999, 341:233-239. 10.1056/NEJM199907223410403, 10413735.
7. Dinubile MJ, Friedland I, Chan CY, Motyl MR, Giezek H, Shivaprakash M, Weinstein RA, Quinn JP. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: Observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis 2005, 24:443-449. 10.1007/s10096-005-1356-0, 15990986.
8. Owens RC, Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis 2006, 42(Suppl 4):S173-181. 10.1086/500664, 16544268.
9. Deplano A, Denis O, Poirel L, Hocquet D, Nonhoff C, Byl B, Nordmann P, Vincent JL, Struelens MJ. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol 2005, 43:1198-1204. 1081292, 15750083, 10.1128/JCM.43.3.1198-1204.2005.
10. D'Arezzo S, Capone A, Petrosillo N, Visca P, Ballardini M, Bartolini S, Bordi E, Di Stefano A, Galiè M, Minniti R, Meledandri M, Pacciani L, Parisi G, Prignano G, Santini C, Valmarin M, Venditti M, Ziantoni S. GRAB Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect 2009, 15:347-357. 10.1111/j.1469-0691.2009.02668.x, 19431222, GRAB.
11. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review of the literature. J Hosp Infect 2006, 64:7-15. 10.1016/j.jhin.2006.04.015, 16822583.
12. Owens RC. Clostridium difficile-associated disease: An emerging threat to patient safety: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2006, 26:299-311. 10.1592/phco.26.3.299, 16503710.
13. Zhanel GG, Decorby M, Nichol KA, Baudry PJ, Karlowsky JA, Lagace-Wiens PR, McCracken M, Mulvey MR, Hoban DJ. Characterization of methicillinresistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (Can-ICU) Study (2005-2006). Can J Infect Dis Med Microbiol 2008, 19:243-249. 2605872, 19412382.
14. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B. Candida spp. Colonization significance in critically ill medical patients: A prospective study. Intensive Care Med 2005, 31:393-400. 10.1007/s00134-005-2571-y, 15711782.
15. Weber JT, Courvalin P. An emptying quiver: Antimicrobial drugs and resistance. Emerg Infect Dis 2005, 11:791-793.
16. Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009, 49:1175-1184. 10.1086/605630, 19739972.
17. Hoffman JM, Shah ND, Vermeulen LC, Doloresco F, Martin PK, Blake S, Matusiak L, Hunkler RJ, Schumock GT. Projecting future drug expenditures - 2009. Am J Health Syst Pharm 2009, 66:237-257. 10.2146/ajhp080636, 19179637.
18. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, . PneumA Trial Group Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003, 290:2588-2598. 10.1001/jama.290.19.2588, 14625336, PneumA Trial Group.
19. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511.
20. Owens RC, Shorr AF, Deschambeault AL. Antimicrobial stewardship: Shepherding precious resources. Am J Health Syst Pharm 2009, 66:S15-22. 10.2146/090087c, 19502223.
21. John JF, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997, 24:471-485.
22. White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997, 25:230-239. 10.1086/514545, 9332517.
23. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997, 157:1689-1694. 10.1001/archinte.157.15.1689, 9250230.
24. LaRocco A. Concurrent antibiotic review programs--a role for infectious diseases specialists at small community hospitals. Clin Infect Dis 2003, 37:742-743. 10.1086/377286, 12942418.
25. Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, Avorn J. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001, 161:1897-1902. 10.1001/archinte.161.15.1897, 11493132.
26. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003, 24:699-706. 10.1086/502278, 14510254.
27. Thursky KA, Buising KL, Bak N, Macgregor L, Street AC, Macintyre CR, Presneill JJ, Cade JF, Brown GV. Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. Int J Qual Health Care 2006, 18:224-231. 10.1093/intqhc/mzi095, 16415039.
28. Bochicchio GV, Smit PA, Moore R, Bochicchio K, Auwaerter P, Johnson SB, Scalea T, Bartlett JG. Pilot study of a web-based antibiotic decision management guide. J Am Coll Surg 2006, 202:459-467. 10.1016/j.jamcollsurg.2005.11.010, 16500251.
29. Paul M, Nielsen AD, Goldberg E, Andreassen S, Tacconelli E, Almanasreh N, Frank U, Cauda R, Leibovici L. Prediction of specific pathogens in patients with sepsis: Evaluation of treat, a computerized decision support system. J Antimicrob Chemother 2007, 59:1204-1207. 10.1093/jac/dkm107, 17449883.
30. Evans RS, Larsen RA, Burke JP, Gardner RM, Meier FA, Jacobson JA, Conti MT, Jacobson JT, Hulse RK. Computer surveillance of hospital-acquired infections and antibiotic use. JAMA 1986, 256:1007-1011. 10.1001/jama.256.8.1007, 3735626.
31. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991, 266:2847-2851. 10.1001/jama.266.20.2847, 1942452.
32. Richards MJ, Robertson MB, Dartnell JG, Duarte MM, Jones NR, Kerr DA, Lim LL, Ritchie PD, Stanton GJ, Taylor SE. Impact of a web-based antimicrobial approval system on broad-spectrum cephalosporin use at a teaching hospital. Med J Aust 2003, 178:386-390.
33. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med 1996, 124:884-890.
34. Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med 2006, 34:2707-2713. 10.1097/01.CCM.0000241151.25426.D7, 16943733.
35. Thiel SW, Asghar MF, Micek ST, Reichley RM, Doherty JA, Kollef MH. Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med 2009, 37:819-824. 10.1097/CCM.0b013e318196206b, 19237883.
36. Zillich AJ, Sutherland JM, Wilson SJ, Diekema DJ, Ernst EJ, Vaughn TE, Doebbeling BN. Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol 2006, 27:1088-1095. 10.1086/507963, 17006817.
37. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005, CD003543.
38. Dellit TH, Chan JD, Skerrett SJ, Nathens AB. Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol 2008, 29:525-533. 10.1086/588160, 18510462.
39. Cook PP, Das TD, Gooch M, Catrou PG. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents. Infect Control Hosp Epidemiol 2008, 29:716-722. 10.1086/589813, 18590455.
40. Haley RW, Shachtman RH. The emergence of infection surveillance and control programs in US hospitals: an assessment, 1976. Am J Epidemiol 1980, 111:574-591.
41. Pope SD, Dellit TH, Owens RC, Hooton TM. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 2009, 30:97-98. 10.1086/592979, 19046053.
42. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474. 10.1378/chest.115.2.462, 10027448.
43. Lawton RM, Fridkin SK, Gaynes RP, McGowan JE. Practices to improve antimicrobial use at 47 US hospitals: The status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000, 21:256-259. 10.1086/501754, 10782587.
44. Barlam TF, DiVall M. Antibiotic-stewardship practices at top academic centers throughout the United States and at hospitals throughout Massachusetts. Infect Control Hosp Epidemiol 2006, 27:695-703. 10.1086/503346, 16807844.
45. Larson EL, Quiros D, Giblin T, Lin S. Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am J Crit Care 2007, 16:110-120. 1853255, 17322010.
46. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998, 280:1233-1237. 10.1001/jama.280.14.1233, 9786372.
47. Paskovaty A, Pflomm JM, Myke N, Seo SK. A multidisciplinary approach to antimicrobial stewardship: Evolution into the 21st century. Int J Antimicrob Agents 2005, 25:1-10. 10.1016/j.ijantimicag.2004.09.001, 15620820.
48. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001, 33:289-295. 10.1086/321880, 11438891.
49. Raineri E, Pan A, Mondello P, Acquarolo A, Candiani A, Crema L. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control 2008, 36:283-290. 10.1016/j.ajic.2007.06.009, 18455049.